BG

Bunge is executing a classic 'Institutional Absorption' play, silently breaking out despite a headline Q4 earnings miss earlier this month. The 'Alpha Male' and 'Seller Fatigue' signals confirm that smart money is looking past the backward-looking YoY declines and aggressively pricing in the Viterra merger synergies, which management confirmed are 'ahead of schedule' ($190M est for 2026). In the current 'Caution' regime, BG acts as a geopolitical hedge (Food/Fuel security), with the upcoming March 10 Investor Day serving as the next major catalyst for a guidance upgrade.